European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 4.750
+0.250 (5.54%)
Oct 9, 2025, 4:45 PM CET
EBR:ALEMS Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 46.78 | 45.13 | 40.56 | 35.27 | 36.27 | - | Upgrade |
Other Revenue | 2.7 | 2.78 | 1.96 | 1.79 | 1.75 | 0.36 | Upgrade |
| 49.47 | 47.91 | 42.53 | 37.06 | 38.02 | 0.36 | Upgrade | |
Revenue Growth (YoY) | 12.63% | 12.67% | 14.76% | -2.53% | 10491.90% | -66.29% | Upgrade |
Cost of Revenue | 31.83 | 30.47 | 27.44 | 23.28 | 24.22 | - | Upgrade |
Gross Profit | 17.64 | 17.45 | 15.09 | 13.78 | 13.8 | 0.36 | Upgrade |
Selling, General & Admin | 12.81 | 13.12 | 12.13 | 11.48 | 11.28 | 1.09 | Upgrade |
Research & Development | - | - | - | - | - | -0.1 | Upgrade |
Other Operating Expenses | 0.74 | 0.75 | 0.8 | 1.93 | 0.47 | 0 | Upgrade |
Operating Expenses | 15.71 | 16.19 | 15.22 | 15.55 | 13.69 | 0.99 | Upgrade |
Operating Income | 1.93 | 1.26 | -0.14 | -1.77 | 0.12 | -0.63 | Upgrade |
Interest Expense | -0.79 | -0.69 | -0.43 | -0.24 | -0.2 | -0.48 | Upgrade |
Interest & Investment Income | - | - | - | 0.01 | - | - | Upgrade |
Currency Exchange Gain (Loss) | 0.06 | 0.08 | -0.1 | -0.07 | -0.07 | 0.05 | Upgrade |
Other Non Operating Income (Expenses) | 0.18 | 0.1 | -0.05 | 0 | 0 | -0.08 | Upgrade |
EBT Excluding Unusual Items | 1.37 | 0.75 | -0.71 | -2.07 | -0.15 | -1.14 | Upgrade |
Gain (Loss) on Sale of Assets | -0 | -0 | - | - | -0.09 | -0.23 | Upgrade |
Asset Writedown | - | - | - | - | - | 0.01 | Upgrade |
Other Unusual Items | - | - | - | -3.52 | - | - | Upgrade |
Pretax Income | 1.37 | 0.75 | -0.71 | -5.58 | -0.24 | -1.36 | Upgrade |
Income Tax Expense | 0.19 | 0.21 | 0 | -0 | -0 | - | Upgrade |
Earnings From Continuing Operations | 1.17 | 0.55 | -0.71 | -5.58 | -0.24 | -1.36 | Upgrade |
Minority Interest in Earnings | - | - | 0 | 0.01 | - | - | Upgrade |
Net Income | 1.17 | 0.55 | -0.71 | -5.58 | -0.24 | -1.36 | Upgrade |
Net Income to Common | 1.17 | 0.55 | -0.71 | -5.58 | -0.24 | -1.36 | Upgrade |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 0 | 0 | Upgrade |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 0 | 0 | Upgrade |
Shares Change (YoY) | - | - | - | 6081.03% | 10.08% | 7.58% | Upgrade |
EPS (Basic) | 0.28 | 0.13 | -0.17 | -1.32 | -3.52 | -21.90 | Upgrade |
EPS (Diluted) | 0.28 | 0.13 | -0.18 | -1.32 | -3.52 | -21.90 | Upgrade |
Free Cash Flow | -0.84 | -1.02 | -4.84 | -0.12 | -1.57 | -1.38 | Upgrade |
Free Cash Flow Per Share | -0.20 | -0.24 | -1.14 | -0.03 | -22.98 | -22.14 | Upgrade |
Gross Margin | 35.66% | 36.41% | 35.48% | 37.18% | 36.31% | 100.00% | Upgrade |
Operating Margin | 3.90% | 2.62% | -0.32% | -4.79% | 0.31% | -175.98% | Upgrade |
Profit Margin | 2.37% | 1.14% | -1.67% | -15.05% | -0.63% | -379.45% | Upgrade |
Free Cash Flow Margin | -1.70% | -2.12% | -11.39% | -0.32% | -4.14% | -383.63% | Upgrade |
EBITDA | 1.35 | 1.32 | 2.06 | 2.32 | 2.05 | -0.51 | Upgrade |
EBITDA Margin | 2.74% | 2.74% | 4.84% | 6.26% | 5.39% | -143.38% | Upgrade |
D&A For EBITDA | -0.58 | 0.06 | 2.2 | 4.09 | 1.93 | 0.12 | Upgrade |
EBIT | 1.93 | 1.26 | -0.14 | -1.77 | 0.12 | -0.63 | Upgrade |
EBIT Margin | 3.90% | 2.62% | -0.32% | -4.79% | 0.31% | -175.98% | Upgrade |
Effective Tax Rate | 14.19% | 27.30% | - | - | - | - | Upgrade |
Advertising Expenses | - | 0.24 | 0.23 | 0.23 | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.